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Some members of the ribonuclease superfamily differ at more than m of the amino acid positions. Although the three- 
dimensional structures probably are very similar and the active-site residues have been conserved, other substrate-binding 
regions have changed considerably. Several proteins in the superfamily are active ribonucleases while others exhibit prac- 
tically no enzymic activity. The presence of a basic residue at either position 66 or 122 appears to be a condition for 
ribonuclease activity. 
Ribonuclease superfamily; Amino acid position; Active site conservation; Ribonuclease activity 
Pancreatic ribonucleases (EC 3.1.27.5) are en- 
zymes which cleave RNA endonucleolytically to 
yield 3 ’ -phosphomono- and -oligonucleotides en- 
ding in Cp or Up, with 2’ ,3 ’ -cyclic phosphate in- 
termediates. The enzyme from bovine pancreas is 
one of the most intensively studied proteins and 
much information has been collected about its 
structure and functional properties [l]. The 
residues in the active site that take care of cleavage 
of the phosphodiester bonds in RNA are well 
characterized, and there are indications of several 
surface positions where other parts of the 
macromolecular substrate may bind [2-41. 
Although pancreatic ribonucleases from other 
mammalian species [5] and other so-called 
secretory ribonucleases, like bovine seminal [6] 
and brain [7] ribonuclease as well, may differ in as 
many as one-third of the amino acid residues in the 
sequence, the general structural organization of 
the enzyme has not changed and residues con- 
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sidered to be important for catalysis and substrate 
binding have been conserved [5]. 
Recently the amino acid sequences of a number 
of more distantly related members of the 
ribonuclease superfamily have been determined. 
These proteins differ at more than 50% of the 
amino acid positions from mammalian pancreatic 
ribonucleases, and several gaps/insertions have to 
be introduced to attain proper alignment. These 
proteins are listed in table 1, and fig.1 presents the 
aligned amino acid sequences of four of them. The 
majority of these proteins have ribonucleolytic ac- 
tivity and can be classified as ribonucleases, but 
the two angiogenins and human eosinophil ca- 
tionic protein have a very low activity on RNA. 
All proteins listed in table 1 probably have about 
the same three-dimensional structure as bovine 
pancreatic ribonuclease. All insertions and gaps 
can be accommodated at external bends [ 11,171. In 
addition, a number of amino acid residues are con- 
served. These include the active-site residues 
His-12, His-119, and Lys-41, 6 half-cystine 
residues which form three of the four disulfide 
bonds in bovine ribonuclease, and 9 other residues 
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Table 1 
Members of the ribonuclease superfamily 
Ribonuclease References 
activitya 
Mammalian pancreatic ribo- 
nucleases + 1S 
Bovine seminal ribonuclease + 6 
Bovine brain ribonuclease + I 
Turtle pancreatic ribonuclease + 8 
Human angiogenin _ 9 
Bovine angiogenin - 10 
Human nonsecretory ribonuclease/ 
eosinophil-derived neurotoxin + 11,12,13, 
20, 21 
Human eosinophil cationic protein - 12,13, 22 
Bovine nonsecretory ribonuclease + 14 
Frog liver ribonuclease + 5 
Frog egg lectin + 5,15 
a Ribonuclease activity: + , active ribonuclease; - , less than 
5% of the specific activity of bovine pancreatic ribonuclease 
(table 2). Although the three active-site residues 
most directly involved in catalysis have been con- 
served, other residues considered to be important 
for enzymic activity or substrate binding have been 
replaced. The very low ribonuclease activities of 
angiogenin and the eosinophil cationic protein 
could be explained if only certain amino acid 
residues were to be replaced in these latter pro- 
teins. However, there are no such residues as will 
be shown in the following examples. 
The aromatic residue (Phe or Tyr) at position 
120 in mammalian ribonucleases is in direct con- 
tact with the pyrimidine ring of the substrate in the 
primary specificity site of the enzyme [1,2]. This 
residue is replaced in human but not in bovine 
angiogenin [9,10]. In studies on semisynthetic 
derivatives of bovine ribonuclease, the replace- 
ment of this residue by leucine has been found to 
lower the specific activity about tenfold [18]. 
Human non-secretory RNase 
Human pancreatic RNase 
Turtle pancreatic PNase 
Human angiogenin 
35 40 45 50 55 60 65 
35 40 
Human non-secretory RNase N 
Human pancreatic RNase P 
Turtle pancreatic RNase F 
Human angiogenin D 
70 75 
I/NI~GNKR~KAI~_ _ 
80 85 90 95 100 
80 a5 90 95 100 
Human non-secretory RNase 
Human pancreatic RNase 
Tljrtle pancreatic RNase 
Human angiogenin 
105 110 115 120 124 128 
Human non-secretory RNase 
Human pancreatjc RNase 
Turtle pancreatic RNase 
Human angiogenin 
Fig. 1. Comparison of the amino acid sequences of human nonsecretory ribonuclease [ll], human pancreatic ribonuclease [16], turtle 
pancreatic ribonuclease [ll], and human angiogenin [9]. Positions are numbered according to the residue number of human 
nonsecretory ribonuclease (upper line) or human pancreatic ribonuclease (lower line). (- ) No amino acid residue present; (?) identity 
unknown. Identical residues in two or more sequences are enclosed in blocks. (Hatched lines) Half-cystine residues; (heavy lines) 
residues in the active site or involved in substrate binding in bovine pancreatic ribonuclease. 
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Table 2 
Invariant residues in members of the ribonuclease superfamily 
Phe-8 
His-12 
Cys-26 
Met-30 
cys-40 
Lvs-4 I 
Asn-44 
Thr-45 
Phe-46 
Cys-58 
Ser-75 
Cvs-84 
Cys-95 
Tyr-91 
cys-110 
Pro-l 17 
Val-118 
His-l 19 
Harper et al. [ 191 studied the enzyme properties of 
a complex of bovine pancreatic ribonuclease 
(residues 1- 118) and a peptide with the amino acid 
sequence of the C-terminal 16 residues of human 
angiogenin. A low ribonuclease activity was 
found. Replacement of leucine at position 120 by 
phenylalanine increased the activity toward low- 
molecular mass substrates up to K&fold, but 
hardly influenced the activity toward RNA. The 
presence of leucine at position 120 in human non- 
secretory ribonuclease also indicates that this 
,120 
replacement cannot explain the low ribonuclease 
activity of human angiogenin. 
Another region which may have a role in the en- 
zymic activity is the surface loop with the disulfide 
bond connecting residues 65 and 72 in bovine 
ribonuclease. It has several substrate-binding sites. 
This loop is shorter in turtle ribonuclease and 
angiogenin, and the two half-cystine residues 
which form a disulfide bond have also been re- 
placed in these proteins. There is an insertion in 
this loop in human non-secretory ribonuclease. If 
this region is important for substrate binding in 
bovine pancreatic ribonuclease, there should be 
other secondary binding sites for substrate in the 
proteins with ribonuclease activity that have 
changed extensively in this loop region. One of the 
more important interactions is that between the 
side chain of lysine 66 and the 5 ’ -phosphate group 
of the nucleotide in the primary pyrimidine- 
binding site. This phosphate-binding site is called 
the P, site [4]. Lysine 66 is present in all mam- 
malian pancreatic and other secretory 
Fig.2. (A) Stereo drawing of part of the structure of bovine pancreatic ribonuclease including active-site residue His-119 and the 
substrate-binding residues Tyr-120 and Lys-66. (B) Same figure with a lysine side chain at the position of Ala-122, demonstrating the 
close vicinity of its positively charged end group and that of Lys-66. 
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ribonucleases [5], but has been replaced in 
members of the ribonuclease superfamily that have 
deletions or insertions in this region. However, tur- 
tle pancreatic ribonuclease and human non- 
secretory ribonuclease have lysine and arginine, 
respectively, at position 122 (fig.]). The positive 
charge of this residue at position 122 probably can 
take over the role of lysine 66 in pancreatic 
ribonucleases (fig.2). Human and bovine 
angiogenin and human eosinophil cationic protein 
have no basic residue at either position (fig.1; 
[9,10,22]. This may explain the very low 
ribonuclease activity of the latter proteins. 
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